Results 201 to 210 of about 3,137,133 (371)

Insulin glargine 300 U/mL safety data in pregnancy. [PDF]

open access: yesDiabetes Obes Metab
Westerbacka J   +4 more
europepmc   +1 more source

300 Porcine CRTC3 [PDF]

open access: yesJournal of Animal Science, 2018
openaire   +2 more sources

Evaluating the use of diagnostic CT with flattening filter free beams for palliative radiotherapy: Dosimetric impact of scanner calibration variability

open access: yesJournal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose Palliative radiotherapy comprises a significant portion of the radiation treatment workload. Volumetric‐modulated arc therapy (VMAT) improves dose conformity and, in conjunction with flattening filter free (FFF) delivery, can decrease treatment times, both of which are desirable in a population with a high probability of retreatment ...
Madeleine L. Van de Kleut   +2 more
wiley   +1 more source

Stereotactic radiotherapy for metastatic brain tumors: A comparative analysis of dose distributions among VMAT, Helical TomoTherapy, CyberKnife, Gamma Knife, and ZAP‐X

open access: yesJournal of Applied Clinical Medical Physics, EarlyView.
Abstract This study evaluates various radiotherapy techniques for treating metastatic brain tumor (BT), focusing on non‐coplanar volumetric modulated arc radiotherapy (NC‐VMAT), coplanar VMAT (C‐VMAT), Helical TomoTherapy (HT), CyberKnife (CK), Gamma Knife (GK), and ZAP‐X.
Toshihiro Suzuki   +9 more
wiley   +1 more source

Impact of acceleration treatment on treatment plan and delivery qualities in tomotherapy for lung cancer

open access: yesJournal of Applied Clinical Medical Physics, EarlyView.
Abstract Background Acceleration treatment (AT) is a novel treatment planning parameter introduced in the tomotherapy‐dedicated treatment planning system, Precision. This study explores the effects of AT on tomotherapy plans using helical (TomoHelical) and direct (TomoDirect) irradiation techniques.
Ryosuke Shirata   +9 more
wiley   +1 more source

A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment. [PDF]

open access: yesRheumatology (Oxford)
Deodhar A   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy